Long-term efficacy of tenofovir alafenamide in HBeAg-positive and -negative chronic hepatitis B patients treated for up to 8 years in 2 phase 3 studies

被引：0

作者：

Buti, Maria ^{[1
,2
]}

Agarwal, Kosh ^{[3
]}

Chan, Henry Ly ^{[4
]}

Seto, Wai-Kay ^{[5
,6
]}

Lim, Young-Suk ^{[7
]}

Brunetto, Maurizia ^{[8
]}

Chuang, Wan-Long ^{[9
]}

Janssen, Harry ^{[10
,11
]}

Fung, Scott ^{[12
]}

Izumi, Namiki ^{[13
]}

Jablkowski, Maciej ^{[14
]}

Abramov, Frida ^{[15
]}

Wang, Hongyuan ^{[15
]}

Yee, Leland ^{[15
]}

Mateo, Roberto ^{[15
]}

Flaherty, John F. ^{[15
]}

Pan, Calvin ^{[16
]}

Shalimar ^{[17
]}

Marcellin, Patrick ^{[18
]}

Gane, Edward J. ^{[19
]}

机构：

[1] Hosp Univ Vall dHebron, Barcelona, Spain

[2] CIBEREHD Inst Carlos III, Madrid, Spain

[3] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England

[4] Chinese Univ Hong Kong, 9F Union Hosp, HMA Off, Tai Wai, Hong Kong, Peoples R China

[5] Univ Hong Kong, Dept Med, Pok Fu Lam, Hong Kong, Peoples R China

[6] Univ Hong Kong, Sch Clin Med, Pok Fu Lam, Hong Kong, Peoples R China

[7] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea

[8] Azienda Osped Univ Pisana, Pisa, Italy

[9] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[10] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[11] Erasmus MC, Rotterdam, Netherlands

[12] Univ Toronto, Dept Med, Toronto, ON, Canada

[13] Japanese Red Cross Musashino Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan

[14] Med Univ Lodz, Lodz, Poland

[15] Gilead Sci Inc, Foster City, CA USA

[16] New York Univ, NYU Langone Hlth, Grossman Sch Med, New York, NY USA

[17] All India Inst Med Sci, New Delhi, India

[18] Hop Beaujon, Hepatol Dept, Clichy, France

[19] Auckland Clin Studies, Symonds St, Auckland, New Zealand

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OS-067

引用

页码：S57 / S57

页数：1

共 50 条

[21] THREE YEARS EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN ASIANS WITH HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B, PRELIMINARY ANALYSIS
Lee, Samuel S.
Heathcote, E. Jenny
Sievert, William
Trinh, Huy N.
Kaita, Kelly D.
Younossi, Zobair M.
George, Jacob
Shiffman, Mitchell L.
Marcellin, Patrick
Sorbel, Jeff
Anderson, Jane
Mondou, Elsa
Ouinn, Joe
Rousseau, Franck
HEPATOLOGY, 2009, 50 (04) : 538A - 538A
[22] Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA
Shi, Hong
Huang, Mingxing
Lin, Guoli
Li, Xiangyong
Wu, Yuankai
Jie, Yusheng
Chong, Yutian
BIOMED RESEARCH INTERNATIONAL, 2016, 2016
[23] Long-term follow-up of HBeAg-positive young adult Japanese patients treated with corticosteroid withdrawal therapy for chronic hepatitis B
Sezaki, Hitorni
Suzuki, Fumitaka
Hosaka, Tetsuya
Akuta, Norio
Someya, Takashi
Kobayashi, Masahiro
Suzuki, Yoshiyuki
Saitoh, Satoshi
Arase, Yasuji
Ikeda, Kenji
Kumada, Hiromitsu
INTERVIROLOGY, 2006, 49 (06) : 339 - 345
[24] Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB)
Pan, Calvin Q.
Brunetto, Maurizia R.
Hui, Aric Josun
Mehta, Rajiv
Flaherty, John F.
Suri, Vithika
Wu, George
Gaggar, Anuj
Subramanian, Mani
Nishiguchi, Shuhei
Kim, Hyung J.
Gane, Edward J.
Chuang, Wan-Long
HEPATOLOGY, 2017, 66 : 482A - 482A
[25] IMPROVED BONE AND RENAL SAFETY AT 1 YEAR AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF): RESULTS FROM 2 PHASE 3 STUDIES IN HBEAG-POSITIVE AND HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Chan, Henry Lek-Yuen
Pan, Calvin
Brunetto, Maurizia
Hui, Aric Josun
Mehta, Rajiv
Flaherty, John F.
Suri, Vithika
Wu, George
Gaggar, Anuj
Subramanian, G. Mani
Nishiguchi, Shuhei
Kim, Hyung Joon
Gane, Edward
Chuang, Wan Long
GUT, 2018, 67 : A97 - A98
[26] Long-term follow up of HBeAg positive chronic hepatitis B treated with gamma and beta
Kishida, Y
Naito, M
Katayama, K
Kashigawa, T
Yoshihara, H
Kamada, T
Akeyama, T
Kasahara, A
Hayashi, N
GASTROENTEROLOGY, 1998, 114 (04) : A1276 - A1276
[27] Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate
Marcellin, Patrick
Buti, Maria
Krastev, Zahari
de Man, Robert A.
Zeuzem, Stefan
Lou, Lillian
Gaggar, Anuj
Flaherty, John F.
Massetto, Benedetta
Lin, Lanjia
Dinh, Phillip
Subramanian, G. Mani
McHutchison, John G.
Flisiak, Robert
Gurel, Selim
Dusheiko, Geoffrey M.
Heathcote, E. Jenny
JOURNAL OF HEPATOLOGY, 2014, 61 (06) : 1228 - 1237
[28] FOUR YEARS EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN ASIANS WITH HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB), PRELIMINARY ANALYSIS
Gane, Edward J.
Lee, Samuel S.
Heathcote, E. Jenny
Sievert, William
Trinh, Huy N.
Kaita, Kelly D.
Younossi, Zobair M.
George, Jacob
Marcellin, Patrick
Coombs, Derek H.
Anderson, Jane
Mondou, Elsa
HEPATOLOGY, 2010, 52 (04) : 559A - 559A
[29] Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies
Okanoue, Takeshi
Shima, Toshihide
Hasebe, Chitomi
Karino, Yoshiyasu
Imazeki, Fumio
Kumada, Takashi
Minami, Masahito
Imai, Yasuharu
Yoshihara, Harumasa
Mita, Eiji
Morikawa, Teruhisa
Nishiguchi, Shuhei
Kawakami, Yoshiiku
Nomura, Hideyuki
Sakisaka, Shotaro
Kurosaki, Masayuki
Yatsuhashi, Hiroshi
Oketani, Makoto
Kohno, Hiroshi
Masumoto, Akihide
Ikeda, Kenji
Kumada, Hiromitsu
HEPATOLOGY RESEARCH, 2016, 46 (10) : 992 - 1001
[30] Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B
Chan, HLY
Hui, AY
Wong, VWS
Chim, AML
Wong, ML
Sung, JJY
HEPATOLOGY, 2005, 41 (06) : 1357 - 1364

← 1 2 3 4 5 →